Spain (ES)

Data-driven modelling of hydraulic-head time series: results and lessons learned from the 2022 Groundwater Time Series Modelling Challenge (2024) Collenteur RA, Haaf E, Bakker M, Liesch T, Wunsch A, Soonthornrangsan J, White J, et al. Journal article Immunogenetics of lithium response and psychiatric phenotypes in patients with bipolar disorder (2024) Herrera-Rivero M, Gutiérrez-Fragoso K, Kurtz J, Baune BT, Thalamuthu A, Amare AT, Adli M, et al. Journal article Exploring the genetics of lithium response in bipolar disorders (2024) Herrera-Rivero M, Adli M, Akiyama K, Akula N, Amare AT, Ardau R, Arias B, et al. Journal article Lithium response in bipolar disorder is associated with focal adhesion and PI3K-Akt networks: a multi-omics replication study (2024) Ou AH, Rosenthal SB, Adli M, Akiyama K, Akula N, Alda M, Amare AT, et al. Journal article A systematic review of progranulin concentrations in biofluids in over 7,000 people—assessing the pathogenicity of GRN mutations and other influencing factors (2024) Swift IJ, Rademakers R, Finch NC, Baker M, Ghidoni R, Benussi L, Binetti G, et al. Journal article The EDELIFE clinical trial, the first investigation of a signalling molecule to treat in utero a human developmental genetic disorder (2024) Schneider H, Hadj-Rabia S, Faschingbauer F, Bodemer C, Grange DK, Guillén-Navarro E, Tadini G, Clarke A Journal article, Original article Trastuzumab deruxtecan in HER2-positive advanced breast cancer with or without brain metastases: a phase 3b/4 trial (2024) Harbeck N, Ciruelos E, Jerusalem G, Müller V, Niikura N, Viale G, Bartsch R, et al. Journal article Early photometric and spectroscopic observations of the extraordinarily bright INTEGRAL-detected GRB 221009A (2024) Sánchez-Ramírez R, Guedes Lang R, Pozanenko A, Martínez-Huerta H, Hu YD, Pandey SB, Gupta R, et al. Journal article A Preoperative Window-of-Opportunity Study of Oral SERD, Imlunestrant, in Newly Diagnosed ER-Positive, HER2-Negative Early Breast Cancer: Results from the EMBER-2 Study (2024) Neven P, Stahl N, Vidal M, Martín M, Kaufman PA, Harbeck N, Hunt KK, et al. Journal article Bispecific antibodies targeting BCMA or GPRC5D are highly effective in relapsed myeloma after CAR T-cell therapy (2024) Merz M, Dima D, Hashmi H, Ahmed N, Stölzel F, Holderried TA, Fenk R, et al. Journal article